The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-04-24
DOI
10.1038/s41419-018-0517-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-to-mesenchymal transition in tumor progression
- (2017) Elena Prieto-García et al. MEDICAL ONCOLOGY
- Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma
- (2016) Hisateru Komatsu et al. ANNALS OF SURGICAL ONCOLOGY
- DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers
- (2016) Ching-Yu Yen et al. CANCER LETTERS
- MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
- (2016) De-Ning Ma et al. Journal of Hematology & Oncology
- Erratum: Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing
- (2016) K-T Lin et al. ONCOGENE
- p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma
- (2016) Yuan Lin et al. ORAL ONCOLOGY
- Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling
- (2016) Sirichat Kaowinn et al. Oncotarget
- Rho kinase mediates Porphyromonas gingivalis outer membrane vesicle-induced suppression of endothelial nitric oxide synthase through ERK1/2 and p38 MAPK
- (2015) Yue Jia et al. ARCHIVES OF ORAL BIOLOGY
- Annexin-A1 controls an ERK-RhoA–NFκB activation loop in breast cancer cells
- (2015) Pradeep Bist et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Actin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tract
- (2015) H T Morris et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
- (2015) Bénédicte Delire et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges
- (2014) Aristeidis G. Vaiopoulos et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PHLPP Is a Negative Regulator of RAF1, Which Reduces Colorectal Cancer Cell Motility and Prevents Tumor Progression in Mice
- (2014) Xin Li et al. GASTROENTEROLOGY
- MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase
- (2014) Rui-Min Chang et al. HEPATOLOGY
- Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells
- (2014) M. Reffay et al. NATURE CELL BIOLOGY
- The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling
- (2014) Tomoyo Okada et al. NATURE CELL BIOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
- (2014) Sheng-Chun Wang et al. PLoS One
- αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
- (2013) Xiao-Yong Huang et al. HEPATOLOGY
- IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways
- (2013) Z Zhang et al. ONCOGENE
- Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma
- (2013) Lu Lu et al. PLoS One
- Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells
- (2013) D. M. Gilkes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in Mice
- (2012) Wei Zhang et al. GASTROENTEROLOGY
- Endometrial carcinoma: molecular alterations involved in tumor development and progression
- (2012) A Yeramian et al. ONCOGENE
- Risk factors of post‐operative recurrence and adequate surgical approach to improve long‐term outcomes of hepatocellular carcinoma
- (2012) Junichi Shindoh et al. HPB
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin
- (2010) Wei Xiong et al. BMC CANCER
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More